Welcome To EURO-NanoTox-Letters

entl2012ISSN: 2074-8515 (electronic only)

Publication Frequency: one issue per year (summary)

Subject: Nanotoxicology, Nanomedicine
Publisher: BioNanoNet Forschungsgesellschaft mbH

entl2014ENTL Issue 2014
entl2011ENTL Issue 2012
entl2011ENTL Issue 2011
entl2010ENTL Issue 2010
entl2009_cover Issue 2009
Please  login/register for FREE to download the issues!


Dear Authors, Dear Readers!

It’s a pleasure to us to welcome you to the circle of interested persons of “EURO-NanoTox-Letters”. This online-journal will assist the communication of high-quality information within our field.

As Editors, our goals are to maximize the quality and relevance of the publication’s content and to ensure, with the help of the advisory board, that we continue to receive world-class submissions that will keep EURO-NanoTox-Letters in the forefront of the field. Ultimately, our success depends on you. We urge you, therefore, to study the guidelines in this document, follow the prescribed procedures for manuscript preparation and delivery, and deliver as closely as possible to deadlines.

Thank you again for agreeing to participate. We look forward to a long and fruitful relationship.

Aim of EURO-NanoTox-Letters

The aim of EURO-NanoTox-Letters is to increase knowledge on interactions of nanoparticles in the physiological context by investigating adsorption, distribution, metabolism and elimination of nanparticles in order to find out to which extent toxicity testing guidelines of drug products for nanoparticles can be used for the assessment of nanoparticles’ toxicity.


Research on the toxic effects of nanoparticles was started by reports that nano-sized combustion products may cause health problems. The potential toxic effects on workers exposed to nanoparticles, which are generated either as by-products during the production or that consist of the final product itself, are another important topic for nanotoxicological research. Increasingly, nanoparticles are also designed for drug-delivery, medical devices and imaging in medicine. Although products, which are used in medical treatment, are subjected to strict guidelines, these guidelines may not apply for nanoparticle-based therapeutics.

} else {